Consolidated PAT +69% YoY on FCIL boost; margins expand, standalone growth mild

Foseco India's consolidated (primary) numbers for Q1 FY27 show revenue of ₹231.41 Cr, up 47.2% YoY and 14.6% QoQ, with PAT of ₹36.40 Cr, up 69.0% YoY and 8.7% QoQ. But this YoY comparison is not like-for-like: the current quarter fully consolidates Foseco Crucible (India) Ltd — formerly Morganite Crucible, acquired in FY26 — while the year-ago comparative is standalone-only (per the filing's own note 5, since the subsidiary wasn't yet part of the group). On a like-for-like standalone basis, the parent's own revenue grew a more modest 15.9% YoY to ₹182.28 Cr and PAT grew just 6.2% YoY to ₹22.86 Cr — and even that muted growth absorbed a ₹3.49 Cr one-off loss booked on the mandatory sale of Open Offer shares in the subsidiary (needed to keep the promoter's stake within SEBI's 75% ceiling); stripping that one-off, standalone PAT would have grown roughly 22% YoY. Margins expanded at the group level: consolidated operating margin (EBITDA excluding other income, over revenue) rose to roughly 23.0% from about 17.3% a year ago and about 21.6% in the preceding quarter, aided by the newly consolidated subsidiary's own record profitability (FCIL's standalone operating margin hit an all-time high near 37%). Net margin improved to 15.4% from 13.3% YoY but slipped slightly from 15.9% QoQ, as the effective tax rate rose to 27.4% this quarter versus about 23.2% in the preceding quarter — the tax drag is worth watching next quarter to see if it normalizes. There is no formal management guidance or prior concall on record for this name, and no analyst consensus/street preview could be found for the standalone entity (a web search surfaced only actual subsidiary-level reporting, not pre-quarter estimates), so vsGuidance and vsStreet are marked unknown rather than assumed. On corporate developments: the board approved acquiring Vesuvius India's Mehsana, Gujarat crucibles/stoppers/sleeves manufacturing facility for a lump-sum ₹43.25 Cr on the same day as results, extending the inorganic expansion theme already visible in this quarter's numbers; the company also completed the FCIL Open Offer share sale (₹11.99 Cr) in June and held its AGM. The results filing itself carries no separate management commentary or press release beyond the standard SEBI outcome letter, so there is no stated management framing to reconcile against the print. Going into Q2 FY27, the print sets up two things to track: whether the subsidiary's newly-consolidated ~23% group operating margin is sustainable once the FCIL purchase-price-allocation adjustments (goodwill revised to ₹409.12 Cr, measurement period runs to 11 November 2026) settle, and how quickly the Mehsana facility acquisition closes and starts contributing.